Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways-Reference-Cited by-同舟云学术

Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways

Published:2022-10-07 Issue:1 Volume:60 Page:1949-1959
ISSN:1388-0209
Container-title:Pharmaceutical Biology
language:en
Short-container-title:Pharmaceutical Biology

Author:

Shen Shuhua¹²,Wang Kungen³,Zhi Yihui³,Dong Yue⁴

Affiliation:

1. Disease Prevention and Health Management Center, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China

2. Disease Prevention and Health Management Center, People’s Hospital of Songyang, Lishui, China

3. Traditional Chinese Internal Medicine Department, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China

4. The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Science and Technology Planning Project of Traditional Chinese Medicine of Zhejiang Province

Publisher

Informa UK Limited

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13880209.2022.2126503

Reference52 articles.

1. Frequency of Firmicutes and Bacteroidetes in gut microbiota in obese and normal weight Egyptian children and adults

2. Nonalcoholic fatty liver disease

3. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

4. The gut microbiome and metabolic syndrome

5. Steatohepatitis: A tale of two “hits”?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A promising therapy for fatty liver disease: PCSK9 inhibitors;Phytomedicine;2024-06

2. The effects of Atractylodes macrocephala extract BZEP self-microemulsion based on gut–liver axis HDL/LPS signaling pathway to ameliorate metabolic dysfunction-associated fatty liver disease in rats;Biomedicine & Pharmacotherapy;2024-06

3. Saponins derived from Gynostemma pentaphyllum regulate triglyceride and cholesterol metabolism and the mechanisms: A review;Journal of Ethnopharmacology;2024-01

4. Mechanisms and Therapeutic Strategies for MAFLD Targeting TLR4 Signaling Pathways;Journal of Innate Immunity;2023-12-21